Atlas Trials

Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma

Clinical trial NCT02624440 · UNKNOWN

Trial details

NCT number
NCT02624440
Sponsor
Henrik Gregersen
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaInfection
Start date
2013-01-01
Primary completion
2016-07-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.